Latest News
Irminix®, a safe metals chelator and antioxidant
Irminix® is an exceptionally safe and effective lipophilic, blood-brain-barrier passing metal chelator and antioxidant being developed by EmeraMed Limited. It is currently going through the European Medical Agency (EMA) and the United States Food and Drug Administration (FDA) drug approval process.
Warning: Counterfeit Irminix® sold illegally in EU & USA
Counterfeit Irminix® is being sold under our various trade names (OSR#1®, NBMI, Emeramide) and tests have shown that it is not Irminix®. Irminix® may be available in your country in compliance with various regulations through our Early Access Programme.
In The Press
Research
The most current, up-to-date information on our research.
Clinical Trials
The most current, up-to-date information on our clinical trials.
Study results from mercury poisoned gold miners
Mercury chelator Irminix® produced outstanding results in safety and efficacy despite the fact that gold miners were overwhelmed with continuous mercury exposure.
Newsletters
Stay up-to-date on EmeraMed with our company newsletters.
EmeraMed Newsletter – February 2019
February 2019 Newsletter for EmeraMed Ltd, a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator & antioxidant Irminix®
Discover The Future of Health
We are committed to improving health by way of our unique metal chelator and antioxidant, Irminix®
